Avior Wealth Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-33
Closed -$6.12K 1517
2024
Q4
$6.12K Buy
33
+3
+10% +$582 ﹤0.01% 1793
2024
Q3
$6.33K Sell
30
-16
-35% -$2.78K ﹤0.01% 1695
2024
Q2
$6.16K Sell
46
-1,029
-96% -$195K ﹤0.01% 1669
2024
Q1
$231K Sell
1,075
-950
-47% -$186K 0.01% 670
2023
Q4
$412K Sell
2,025
-652
-24% -$106K 0.03% 384
2023
Q3
$531K Buy
2,677
+288
+12% +$72.6K 0.04% 313
2023
Q2
$776K Buy
2,389
+253
+12% +$72.3K 0.05% 241
2023
Q1
$500K Buy
2,136
+693
+48% +$175K 0.03% 345
2022
Q4
$363K Hold
1,443
0.03% 373
2022
Q3
$255K Buy
1,443
+254
+21% +$51K 0.02% 416
2022
Q2
$217K Buy
1,189
+303
+34% +$60.4K 0.02% 407
2022
Q1
$227K Buy
+886
New +$202K 0.02% 419

Other funds holding INSP

Avior Wealth Management's INSP Position: Q1 2025 in Review

Avior Wealth Management sold out of Inspire Medical Systems (INSP) in Q1 2025, closing a stake of 33 shares — an estimated $6.12K sold.

Avior Wealth Management first reported a position in INSP in Q1 2022 and held it in 12 quarters. The position peaked at $776K in Q2 2023. 363 funds tracked by Wall St. Rank hold INSP as of Q1 2025.

  • Avior Wealth Management reported no remaining Inspire Medical Systems position as of Q1 2025 after selling out during the quarter.
  • Avior Wealth Management sold 33 Inspire Medical Systems shares in Q1 2025, an estimated $6.12K.
  • Avior Wealth Management first reported a position in Inspire Medical Systems in Q1 2022 and held it in 12 quarters.
  • Avior Wealth Management's Inspire Medical Systems position peaked at $776K in Q2 2023.
  • 363 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2025.

Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.